The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-L1 as a predictor of chemo-immunotherapy response in biliary tract cancers: A systematic review and meta-analysis.
 
Juan Jose Juarez
No Relationships to Disclose
 
Soravis Alm Osataphan
No Relationships to Disclose
 
Ben Ponvilawan
No Relationships to Disclose
 
Nipith Charoenngam
No Relationships to Disclose
 
Mary Linton Bounetheau Peters
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbott Laboratories (I); Agios; Amgen (I); Johnson & Johnson (I); Lilly; Lilly (I); Medtronic; Medtronic (I); Merck; Merck (I); Pfizer (I); Procter & Gamble
Research Funding - AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Berg Pharma (Inst); Exelixis (Inst); Helsinn Therapeutics (Inst); Lilly (Inst); Merck (Inst); Nucana (Inst); Taiho Pharmaceutical (Inst)